Figure S2. Effect of combinations of olaparib and ionizing radiation on the formation of γH2AX and 53BP1 foci in response to DNA damage in H1299 (TP53−/−) cells. a. Effect of different doses of either olaparib or ionizing radiation on the formation of γH2AX and 53BP1 foci in response to DNA damage. b. Effect of combinations of olaparib and ionizing radiation on the formation of γH2AX and 53BP1 foci. c. Quantification of the effect of olaparib and IR by themselves or in combination on the number of γH2AX foci. d. Quantification of the effect of olaparib and IR, by themselves or in combination on the number of 53BP1 foci. ns: not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. (PDF 350 kb
Figures S1-S5. Figure S1. Survival curves for irradiation of cells (V79, MCF7, HUVEC) in vitro with ...
Figure S1. Clonogenic survival of wild-type U2-OS cells exposed to different doses of ionizing radia...
Table S1. PCR primers; Table S2. Complete set of genes analyzed in the manuscript; Table S3 A GO ter...
Figure S3. Effect of combinations of olaparib and ionizing radiation on the formation of γH2AX and 5...
Figure S1. Effect of combinations of olaparib and ionizing radiation on the formation of γH2AX and 5...
Figure S9. Effect of VRK1 depletion on the formation of γH2AX and 53BP1 foci induced by olaparib, IR...
Figure S8. Effect of VRK1 depletion on nuclear NBS1 fluorescence induced by olaparib, IR or their co...
Figure S7. Effect of VRK1 depletion on nuclear NBS1 fluorescence induced by olaparib, IR or their co...
Figure S10. H4K16ac induced by olaparib is independent of ATM. A. Effect of VRK1 depletion on H4K16 ...
Figure S4. Effect of VRK1 depletion on the nuclear fluorescence associated to the acetylation of his...
Table S1. Cell cycle-phase distribution in control and irradiated (2 or 8 Gy) SNB19 tumor cells. The...
KC-53 induces DNA damage in HL-60 and CCRF/CEM cells. HL-60 and CCRF/CEM cells were treated with veh...
Figure S1. Synergistic growth-inhibition between AZD1775 and olaparib in GC cells. After GC cells we...
TTFields effect on LN-18 glioma cells. Surviving fractions of LN-18 cells treated with TTFields (200...
Figure S2. Rapamycin treatment inhibited activation of TGF-β and NF-κB signaling induced by irradiat...
Figures S1-S5. Figure S1. Survival curves for irradiation of cells (V79, MCF7, HUVEC) in vitro with ...
Figure S1. Clonogenic survival of wild-type U2-OS cells exposed to different doses of ionizing radia...
Table S1. PCR primers; Table S2. Complete set of genes analyzed in the manuscript; Table S3 A GO ter...
Figure S3. Effect of combinations of olaparib and ionizing radiation on the formation of γH2AX and 5...
Figure S1. Effect of combinations of olaparib and ionizing radiation on the formation of γH2AX and 5...
Figure S9. Effect of VRK1 depletion on the formation of γH2AX and 53BP1 foci induced by olaparib, IR...
Figure S8. Effect of VRK1 depletion on nuclear NBS1 fluorescence induced by olaparib, IR or their co...
Figure S7. Effect of VRK1 depletion on nuclear NBS1 fluorescence induced by olaparib, IR or their co...
Figure S10. H4K16ac induced by olaparib is independent of ATM. A. Effect of VRK1 depletion on H4K16 ...
Figure S4. Effect of VRK1 depletion on the nuclear fluorescence associated to the acetylation of his...
Table S1. Cell cycle-phase distribution in control and irradiated (2 or 8 Gy) SNB19 tumor cells. The...
KC-53 induces DNA damage in HL-60 and CCRF/CEM cells. HL-60 and CCRF/CEM cells were treated with veh...
Figure S1. Synergistic growth-inhibition between AZD1775 and olaparib in GC cells. After GC cells we...
TTFields effect on LN-18 glioma cells. Surviving fractions of LN-18 cells treated with TTFields (200...
Figure S2. Rapamycin treatment inhibited activation of TGF-β and NF-κB signaling induced by irradiat...
Figures S1-S5. Figure S1. Survival curves for irradiation of cells (V79, MCF7, HUVEC) in vitro with ...
Figure S1. Clonogenic survival of wild-type U2-OS cells exposed to different doses of ionizing radia...
Table S1. PCR primers; Table S2. Complete set of genes analyzed in the manuscript; Table S3 A GO ter...